Regenxbio Completes Dosing in Confirmatory Study of Rgx-202, Marking Completion of Registrational Development Program and Supporting Planned Bla Submission in Q3 2026 PR Newswire (Press Release) 4d
FDA changes rare disease tune again as it clears path for Regenxbio’s gene therapy Pharmaceutical Technology 5d
FDA reports efforts prevented 450K youth from vaping Tobacco Reporter Magazine 3d Vaping Tobacco All sources
FDA Panel Backs Moderna's First mRNA Flu Shot — What It Could Mean for Your Fall Vaccine Medical Daily 3d Moderna mRNA Flu All sources
Cheese sold in NJ recalled amid listeria concerns, FDA says Patch 2d Listeria Maryland New Jersey All sources
